There are also significant positive correlations between JAM-A and HER2 gene expression in multiple other cancers, specifically 30/40 or 75% of The Cancer Genome Atlas (TCGA) subclassifications that can be interrogated on the online platform timer.cistrome.org [29,30] (accessed on 15 December 2021). This evidence concerns the gene F11R and cancer.